Document Detail


Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma.
MedLine Citation:
PMID:  20717826     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
PURPOSE: The aim of this study was to assess the usefulness of positron emission tomography/computed tomography in staging, prognosis evaluation and restaging of patients with follicular lymphoma.
METHODS: A retrospective study was performed on 45 patients with untreated biopsy-proven follicular lymphoma who underwent 18F-fluorodeoxyglucose PET/CT (FDG PET/CT) and CT before and after chemoimmunotherapy induction treatment (rituximab combined with cyclophosphamide, doxorubicin, vincristine and prednisone).
RESULTS: PET/CT detected more nodal (+51%) and extranodal (+89%) lesions than CT. PET/CT modified Ann Arbor staging in eight patients (18%). Five patients (11%) initially considered as being early stage (I/II) were eventually treated as advanced stage (III/IV). In this study, an initial PET/CT prognostic score was significantly more accurate than the Follicular Lymphoma International Prognostic Index score in identifying patients with poor prognosis (i.e. patients with incomplete therapeutic response or early relapse). The accuracy of PET/CT for therapeutic response assessment was higher than that of CT (0.97 vs 0.64), especially due to its ability to identify inactive residual masses. In addition, post-treatment PET/CT was able to predict patients' outcomes. The median progression-free survival was 48 months in the PET/CT-negative group as compared with 17.2 months for the group with residual uptake (p<10(-4)).
CONCLUSION: FDG PET/CT is useful for staging and assessing the prognosis and therapeutic response of patients with follicular lymphoma.
Authors:
Ludovic Le Dortz; Sophie De Guibert; Sahar Bayat; Anne Devillers; Roch Houot; Yan Rolland; Marc Cuggia; Florence Le Jeune; Haïfa Bahri; Marie-Luce Barge; Thierry Lamy; Etienne Garin
Related Documents :
9275976 - Imaging approach to staging of renal cell carcinoma.
15299056 - Is 18f-fdg pet more accurate than standard diagnostic procedures in the detection of su...
20850026 - Diagnostic accuracy of ultrasound and 18-f-fdg pet or pet/ct for patients with suspecte...
14530496 - Pet scans in the staging of lymphoma: current status.
18227546 - Obscure gastrointestinal bleeding: evaluation with 64-section multiphase ct enterograph...
15354336 - Magnetic resonance imaging of the intrauterine fetal genitourinary tract: normal anatom...
Publication Detail:
Type:  Journal Article     Date:  2010-08-18
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  37     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  2307-14     Citation Subset:  IM    
Affiliation:
Nuclear Medicine Department, Eugène Marquis Anticancer Centre, Rennes, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/...
Next Document:  A case of non-cardiogenic acute pulmonary edema in a patient with POEMS syndrome-associated pulmonar...